CV Sciences Sales Down 10 Percent
Operating income turned positive, mostly due to a $0.5 million one-time benefit, with actual operating income of $11,000, but adjusted EBITDA remains negative. These 10 stocks could mint the next wave …
2 Stocks Down More Than 90% That Still Aren’t Worth Buying
Now, it’s worth noting Stock Advisor’s total average return is 1,060% — a market-crushing outperformance compared to 182% for the S&P 500. Don’t miss out on the latest top 10 list, available when you …
Neural Therapeutics Acquires Stake in German CBD Retailer Hanf.com
An announcement from Neural Therapeutics Inc. ( ($TSE:NURL) ) is now available. Neural Therapeutics Inc. has completed the acquisition of a 30.75% …
CenTex CBD is closing their doors amidst uncertainty and political debate
The ongoing battle to ban THC in Texas led to their decision.
Cardiol Therapeutics’ stock down 20% on Phase II CardiolRx failure
CardiolRx did not have a significant impact on left ventricular extracellular volume (LV-ECV) in the Phase II ARCHER study.
CBD Stocks Creating Opportunities – Established (BCCI), (STG), (WEED), (ACRGF), (RLTR), (CBMJ), and Newcomer (VAPR) Lead the Charge
You would have to be living in isolation to have not picked up on the hottest marijuana derivative consumable and therapeutic center isolate CBD. CBD “Cannabidiol” is the non-psychoactive full spectrum derivative of the hemp and marijuana plant largely credited for the majority of the medical beneficial attributes associated with marijuana.
Innocan Pharma’s LPT-CBD Injections Transform Animal Care at Freedom Farm
InnoCan Pharma ( ($TSE:INNO) ) just unveiled an announcement. Innocan Pharma has partnered with Freedom Farm to provide its LPT-CBD injections for …
Surge in investor confidence boosts Cape Town CBD property development values to R9. 031 billion
In a remarkable display of resilience and growth, investor confidence in Cape Town’s Central Business District (CBD) has surged in 2024/25, with property development values leapfrogging to an …
CBD Life Sciences Inc. (CBDL) Huge Momentum Following NECANN New Jersey 2025
The U.S. marijuana dispensary market is projected to generate over $31.8 billion annually by 2025, creating multi-million-dollar opportunities for CBDL through dispensary partnerships and large-scale …
Sydney to see eight new office projects until Q4 2027
These will yield nearly 200,000sqm of stock. There were three office completions in Sydney totalling 46,900 sqm over the second quarter and no withdrawals in the CBD, according to a JLL report. There …
INVESCO Ltd. stock underperforms Wednesday when compared to competitors
Shares of INVESCO Ltd. IVZ slid 1.10% to $21.48 Wednesday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index SPX falling 0.12% to 6,362.90 and Dow …
Why value investing has worked better outside the US
While value has outperformed growth in Europe over the past five years, Europe now represents less than half of equity market capitalization outside the US. Rather, value stocks in emerging markets …
CENTR Brands Corp. Closes $150,000 Private Placement to Bolster Financial Position
CENTR Brands ( ($TSE:CNTR) ) just unveiled an update. CENTR Brands Corp. has successfully closed a non-brokered private placement of unsecured …
Tilray Medical Study Finds Oral THC:CBD Extract Offers Faster, Higher Bioavailability
Tilray Brands Inc. (NASDAQ:TLRY) is one of the best penny stocks under $1 to buy now. On June 26, Tilray Brands, through its medical division, Tilray Medical, published a new scientific study on the …
InnoCan Pharma Stock: Nasdaq Listing Filing Signals Major Leap
InnoCan Pharma has officially filed registration documents with the SEC for a Nasdaq listing on July 23, 2025, marking a transformative moment for the Israeli-Canadian biotech company. The …
Recent Comments